ReviewiScience2025
Revisiting harmful algal blooms in India through a global lens: An integrated framework for enhanced research and monitoring.
Review in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Harmful algal bloom (HAB) events substantially impact human and aquatic ecosystem health and the global blue economy; hence, a concerted effort is required to advance our understanding of HAB ecology to better inform monitoring and mitigation measures. Here, we highlight the current state of HAB research and monitoring in India, where ∼17% of the human population resides in the vicinity of its long coastline and is dependent on the sustainable blue economy. Through the lens of established programs from countries across the globe, we identify existing gaps and highlight four broad areas for focusing future efforts: (1) the development/employment of novel technologies for HAB research and monitoring; (2) the need for integrated observation networks and a coordinated effort across different central/state agencies and research institutes; (3) clinical studies on human health effects; and (4) public outreach and citizen science initiatives to increase awareness on this topic, including policy level interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.